Drug treatment of the chronic idiopathic glomerulopathies.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002908:Chronic Disease; D004176:Dipyridamole / Q000627:therapeutic use; D005492:Folic Acid / Q000031:analogs & derivatives; D005921:Glomerulonephritis / Q000188:drug therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents; D007213:Indomethacin / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy / Q000276:immunology; D007678:Kidney Glomerulus / Q000473:pathology; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000276:immunology; D010956:Plasmapheresis; D011507:Proteinuria / Q000188:drug therapy / Q000276:immunology; D011687:Purines / Q000037:antagonists & inhibitors; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D007166:Immunosuppressive Agents; D011687:Purines; D004176:Dipyridamole; D005492:Folic Acid; D007213:Indomethacin